Science and Research

CYP19A1 mediates severe SARS-CoV-2 disease outcome in males

Male sex represents one of the major risk factors for severe COVID-19 outcome. However, underlying mechanisms that mediate sex-dependent disease outcome are as yet unknown. Here, we identify the CYP19A1 gene encoding for the testosterone-to-estradiol metabolizing enzyme CYP19A1 (also known as aromatase) as a host factor that contributes to worsened disease outcome in SARS-CoV-2-infected males. We analyzed exome sequencing data obtained from a human COVID-19 cohort (n = 2,866) using a machine-learning approach and identify a CYP19A1-activity-increasing mutation to be associated with the development of severe disease in men but not women. We further analyzed human autopsy-derived lungs (n = 86) and detect increased pulmonary CYP19A1 expression at the time point of death in men compared with women. In the golden hamster model, we show that SARS-CoV-2 infection causes increased CYP19A1 expression in the lung that is associated with dysregulated plasma sex hormone levels and reduced long-term pulmonary function in males but not females. Treatment of SARS-CoV-2-infected hamsters with a clinically approved CYP19A1 inhibitor (letrozole) improves impaired lung function and supports recovery of imbalanced sex hormones specifically in males. Our study identifies CYP19A1 as a contributor to sex-specific SARS-CoV-2 disease outcome in males. Furthermore, inhibition of CYP19A1 by the clinically approved drug letrozole may furnish a new therapeutic strategy for individualized patient management and treatment.

  • Stanelle-Bertram, S.
  • Beck, S.
  • Mounogou, N. K.
  • Schaumburg, B.
  • Stoll, F.
  • Al Jawazneh, A.
  • Schmal, Z.
  • Bai, T.
  • Zickler, M.
  • Beythien, G.
  • Becker, K.
  • de la Roi, M.
  • Heinrich, F.
  • Schulz, C.
  • Sauter, M.
  • Krasemann, S.
  • Lange, P.
  • Heinemann, A.
  • van Riel, D.
  • Leijten, L.
  • Bauer, L.
  • van den Bosch, T. P. P.
  • Lopuhaä, B.
  • Busche, T.
  • Wibberg, D.
  • Schaudien, D.
  • Goldmann, T.
  • Lüttjohann, A.
  • Ruschinski, J.
  • Jania, H.
  • Müller, Z.
  • Pinho Dos Reis, V.
  • Krupp-Buzimkic, V.
  • Wolff, M.
  • Fallerini, C.
  • Baldassarri, M.
  • Furini, S.
  • Norwood, K.
  • Käufer, C.
  • Schützenmeister, N.
  • von Köckritz-Blickwede, M.
  • Schroeder, M.
  • Jarczak, D.
  • Nierhaus, A.
  • Welte, T.
  • Kluge, S.
  • McHardy, A. C.
  • Sommer, F.
  • Kalinowski, J.
  • Krauss-Etschmann, S.
  • Richter, F.
  • von der Thüsen, J.
  • Baumgärtner, W.
  • Klingel, K.
  • Ondruschka, B.
  • Renieri, A.
  • Gabriel, G.

Keywords

  • Covid-19
  • Cyp19a1
  • estradiol
  • letrozole
  • lung health
  • male sex
  • testosterone
Publication details
DOI: 10.1016/j.xcrm.2023.101152
Journal: Cell Rep Med
Pages: 101152 
Work Type: Original
Location: ARCN, BREATH
Disease Area: PALI
Partner / Member: FZB, MHH
Access-Number: 37572667

DZL Engagements

chevron-down